Potassium Chloride NDC 63323-965

NDC codes

FDA NDC Directory

Product NDC (as listed)63323-965Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63323-0965Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
63323-965-05	63323096505	25 VIAL, SINGLE-DOSE in 1 TRAY (63323-965-05) / 5 mL in 1 VIAL, SINGLE-DOSE (63323-965-01)Marketed from Sep 27, 1999
63323-965-10	63323096510	25 VIAL, SINGLE-DOSE in 1 TRAY (63323-965-10) / 10 mL in 1 VIAL, SINGLE-DOSE (63323-965-03)Marketed from Sep 27, 1999
63323-965-20	63323096520	25 VIAL, SINGLE-DOSE in 1 TRAY (63323-965-20) / 20 mL in 1 VIAL, SINGLE-DOSE (63323-965-02)Marketed from Sep 27, 1999

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Potassium Chloride
Generic name (nonproprietary): potassium chloride
Active ingredients: Potassium chloride — 2 meq/mL
Dosage form: Injection, Solution, Concentrate
Route: Intravenous
Labeler: Fresenius Kabi USA, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 088901
Marketing start: Sep 27, 1999
Listing expires: Dec 31, 2026
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)
Identifiers: Product ID 63323-965_a1b31b46-2bb4-457e-a30b-e7dab47a2c54SPL ID a1b31b46-2bb4-457e-a30b-e7dab47a2c54SPL set ID fcd4f458-ce27-417e-9bb6-de1cc49d44b9RxCUI 204520, 1860132, 1860136, 1860139UNII 660YQ98I10UPC 0363323967017, 0363323965020, 0363323965013
Pharmacologic class: Osmotic Laxative; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N463323096505 followed by a unit qualifier and the quantity

Package 63323-0965-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 27, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE: Potassium Chloride for Injection Concentrate, USP is indicated in the treatment of potassium deficiency states when oral replacement is not feasible.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 088901

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 088901
Product	Strength	Form · route	Labeler	Product NDC
Potassium Chloride	Potassium chloride 2 meq/mL	Injection, Solution, ConcentrateIntravenous	Henry Schein, Inc.	0404-9936